These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12694162

  • 1. Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
    Rudzki Z, Okoń K, Machaczka M, Rucińska M, Papla B, Skotnicki AB.
    Eur J Haematol; 2003 May; 70(5):273-81. PubMed ID: 12694162
    [Abstract] [Full Text] [Related]

  • 2. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.
    Mistry PK, Weinreb NJ, Kaplan P, Cole JA, Gwosdow AR, Hangartner T.
    Blood Cells Mol Dis; 2011 Jan 15; 46(1):66-72. PubMed ID: 21112800
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
    Poll LW, Koch JA, vom Dahl S, Willers R, Scherer A, Boerner D, Niederau C, Häussinger D, Mödder U.
    Skeletal Radiol; 2001 Sep 15; 30(9):496-503. PubMed ID: 11587517
    [Abstract] [Full Text] [Related]

  • 4. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
    Poll LW, vom Dahl S, Koch JA, Börner D, Willers R, Cohnen M, Jung G, Scherer A, Niederau C, Häussinger D, Mödder U.
    Rofo; 2001 Oct 15; 173(10):931-7. PubMed ID: 11588682
    [Abstract] [Full Text] [Related]

  • 5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 15; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 6. Long-term bone mineral density response to enzyme replacement therapy in a retrospective pediatric cohort of Gaucher patients.
    Ciana G, Deroma L, Franzil AM, Dardis A, Bembi B.
    J Inherit Metab Dis; 2012 Nov 15; 35(6):1101-6. PubMed ID: 22441841
    [Abstract] [Full Text] [Related]

  • 7. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, Hangartner TN.
    J Bone Miner Res; 2007 Jan 15; 22(1):119-26. PubMed ID: 17032149
    [Abstract] [Full Text] [Related]

  • 8. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
    El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, Mansour IM, Abd El-Hamid S, Yang M, Mistry PK.
    J Inherit Metab Dis; 2006 Feb 15; 29(1):92-8. PubMed ID: 16601874
    [Abstract] [Full Text] [Related]

  • 9. Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Mistry PK, Batista JL, Andersson HC, Balwani M, Burrow TA, Charrow J, Kaplan P, Khan A, Kishnani PS, Kolodny EH, Rosenbloom B, Scott CR, Weinreb N.
    Am J Hematol; 2017 Sep 15; 92(9):929-939. PubMed ID: 28569047
    [Abstract] [Full Text] [Related]

  • 10. Bone complications in children with Gaucher disease.
    Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ.
    Br J Radiol; 2002 Sep 15; 75 Suppl 1():A37-44. PubMed ID: 12036831
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K, Moos L, Mengel E, Lollert A, Hoffmann C, Brixius-Huth M, Wagner D, Düber C, Staatz G.
    Blood Cells Mol Dis; 2016 Mar 15; 57():35-41. PubMed ID: 26852653
    [Abstract] [Full Text] [Related]

  • 12. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 13. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
    Lebel E, Elstein D, Peleg A, Reinus C, Zimran A, Amir G.
    Am J Clin Pathol; 2013 Jul 20; 140(1):91-6. PubMed ID: 23765538
    [Abstract] [Full Text] [Related]

  • 14. Response of Gaucher bone disease to enzyme replacement therapy.
    Poll LW, Maas M, Terk MR, Roca-Espiau M, Bembi B, Ciana G, Weinreb NJ.
    Br J Radiol; 2002 Jul 20; 75 Suppl 1():A25-36. PubMed ID: 12036830
    [Abstract] [Full Text] [Related]

  • 15. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
    Lin HY, Lin SP, Chuang CK, Wraith JE.
    J Chin Med Assoc; 2006 May 20; 69(5):228-32. PubMed ID: 16835986
    [Abstract] [Full Text] [Related]

  • 16. Body composition and bone metabolism in young Gaucher disease type I patients treated with imiglucerase.
    Parisi MS, Mastaglia SR, Bagur A, Goldstein G, Zeni SN, Oliveri B.
    Eur J Med Res; 2008 Jan 23; 13(1):31-8. PubMed ID: 18226995
    [Abstract] [Full Text] [Related]

  • 17. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
    Mikosch P, Reed M, Baker R, Holloway B, Berger L, Mehta AB, Hughes DA.
    Calcif Tissue Int; 2008 Jul 23; 83(1):43-54. PubMed ID: 18553043
    [Abstract] [Full Text] [Related]

  • 18. Enzyme replacement therapy with imiglucerase in Taiwanese patients with type I Gaucher disease.
    Hsu CC, Chien YH, Lai MY, Hwu WL.
    J Formos Med Assoc; 2002 Sep 23; 101(9):627-31. PubMed ID: 12645190
    [Abstract] [Full Text] [Related]

  • 19. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady RO.
    J Nucl Med; 2003 Aug 23; 44(8):1253-62. PubMed ID: 12902415
    [Abstract] [Full Text] [Related]

  • 20. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.
    Tezuka Y, Fukuda M, Watanabe S, Nakano T, Okamoto K, Kuzume K, Yano Y, Eguchi M, Ishimae M, Ishii E, Miyazaki T.
    Blood Cells Mol Dis; 2018 Feb 23; 68():194-199. PubMed ID: 27866810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.